Sisram MedicalSRAMF 60 Gross Margin % is 57.94% as of Dec. 2025, which is 3% above its 10-year median of 56.21. GuruFocus rates SRAMF with a GF Score™ of 60/100 and a GF Value™ of $0.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Sisram Medical ranks better than 60.5% on this metric.
The historical rank and industry rank for Sisram Medical's Gross Margin % or its related term are showing as below:
SRAMF'
s Gross Margin % Range Over the Past 10 Years
Min: 52.66 Med: 56.21 Max: 62.07
Current: 58.89
During the past 12 years, the highestGross Margin % of Sisram Medical was 62.07%. The lowest was 52.66%. And the median was 56.21%.
SRAMF's Gross Margin % is ranked better than 60.5% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs SRAMF: 58.89
Sisram Medical had a gross margin of 57.94% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Sisram Medical was 1.80% per year.
Sisram Medical (OTCPK:SRAMF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sisram Medical had a gross margin of 57.94% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sisram Medical Gross Margin % Related Terms
Sisram Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sisram Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sisram Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sisram Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sisram Medical (SRAMF) has a Gross Margin % of 57.94% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Sisram Medical and its competitors. This is near median its historical median of 56.21. Over the past decade, Sisram Medical's Gross Margin % has ranged from 52.66 to 62.07. According to the industry distribution chart, Sisram Medical ranks #318 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 39.5%.
Is Sisram Medical's Gross Margin % too high?
Sisram Medical's current Gross Margin % of 57.94% is near median its 10-year median of 56.21. Over the past 10 years, this metric has ranged from a low of 52.66 to a high of 62.07. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Sisram Medical's value of 57.94% is 11.3% above this industry median. Based on the distribution chart, Sisram Medical ranks #318 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sisram Medical has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #318 out of 805 companies for Gross Margin %. This puts Sisram Medical in the upper half of its industry. The industry median Gross Margin % is 52.07. Sisram Medical's value of 57.94% is 11.3% above this benchmark. Historically, Sisram Medical's own Gross Margin % has ranged from 52.66 to 62.07 over the past decade. While the company's 10-year median is 56.21 vs. the industry median of 52.07, Sisram Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sisram Medical's current Gross Margin % of 57.94% is 11.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sisram Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sisram Medical's current Gross Margin % is 57.94%, which is near median its own 10-year median of 56.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.95, compared to a current price of $0.44 — trading 53.9% below its estimated fair value. The current Gross Margin % is 57.94%, which is near median its 10-year median of 56.21 and 11.3% above the Medical Devices & Instruments industry median of 52.07. Sisram Medical's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current Gross Margin % is 57.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sisram Medical (SRAMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued.
The current stock price of $0.44 is trading 53.9% below its estimated GF Value™ of $0.95.
GuruFocus considers Sisram Medical to be Significantly Undervalued.
Key valuation signals for SRAMF:
Gross Margin %: 57.94% (near median its 10-year median of 56.21)
GF Value™: $0.95 vs. price of $0.44 (53.9% below fair value)
Industry Position: 11.3% above the Medical Devices & Instruments median (#318 of 805)
No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
60GF Score
Get the complete analysis for SRAMF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRAMF has been successfully added to your 
